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ABSTRACT 
 
HYPERBARIC OXYGEN THERAPY EFFECT ON CONTRAST 
SENSITIVITY AND MACULAR LIGHT SENS ITIVITY IN DRY TYPE 
AGE RELATED MACULAR DEGENERATION PATIENTS 
Indriani Kartika Dewi, Moestidjab, Titut Harnanik 
 
Objective : To compare the effectiveness of hyperbaric oxygen therapy on 
contrast sensitivity and macular light sensitivity improvement in stage 1, 2, and 3 
of dry type age related macular degeneration (AM D) patients based on AREDS 
classification. 
 
Methods : This clinical research was using quasi-experimental design. The 
subjects were eyes of ophthalmology outpatient clinic patients at RSUD Dr. 
Soetomo that had been diagnosed with stage 1, 2, or 3 of dry type AMD which 
met inclusion criteria. They were divided into two groups. The first group were 
given antioxidants and hyperbaric oxygen therapy (HBOT) with 100% oxygen 
under 2.4 ATA pressure for 3 x 30 minutes with 5 minutes resting phase each day 
for four days. The second group were control group and being given antioxidants 
only. The subjects then underwent some examinations which are contrast 
sensitivity using MARS contrast sensitivity chart and macular light sensitivity 
using Humphrey Field Analyzer-3 for three times, pre-therapy, day-1 and 14 post 
therapy. 
 
Result : 26 eyes from 16 patients were enrolled into the study, one subject refused 
to continue and therefore drop out. 25 eyes were included in to analysis, divided 
into two groups, 14 subjects in first group and 11 subjects in second group. There 
is no significant difference between both groups from distribution of gender, age, 
diabetes, hypertension, and obesity status. Statistical analysis results show there 
are significant increase on contrast sensitivity in intervention group between one-
day post-therapy with pre-therapy (p=0.003), and between 14-days post-therapy 
with pre-therapy (p=0,015). There is no significant difference found on contrast 
sensitivity on control group. For macula light sensitivity, there is no significant 
difference found in the intervention group. For the control group, there is 
significant increase on superotemporal area between one-day post-therapy and 
pra-therapy (p=0.004), superonasal area between one-day post-therapy and pra-
therapy (p=0.013), inferonasal area between one-day post-therapy and pra-therapy 
(p=0.008), and there is significant decrease on inferonasal area between 14-day 
post-therapy and one-day post-therapy (p=0.003). 
 
Conclusion : In this study 14 subjects with AMD underwent HBOT and achieved 
improvement in contrast sensitivity in cases considered low prognosis. There were 
minor complications but treatable. HBOT should be considered as a promising 
intervention for AMD management and further research are needed to find the 
optimal dosage. 
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